Will Biogen’s Drug Aducanumab Solve the Alzheimer’s Mystery?
Last week, Biogen announced that its Alzheimer’s drug aducanumab was effective in combating Alzheimer’s disease, and that it would be reviving a trial cancelled…
Last week, Biogen announced that its Alzheimer’s drug aducanumab was effective in combating Alzheimer’s disease, and that it would be reviving a trial cancelled…
In the first study published about Alzheimer’s disease among identical triplets, researchers in Canada suggest that the development of dementia is not exclusively linked…
Lonni Schicker had spent most of her life being active, and working as a nurse and a teacher — but that all changed when…
Neurodegenerative diseases like Alzheimer’s and dementia are caused by specific protein clumps — like tau or beta amyloid. But researchers are still investigating how…
Can that morning cup of coffee actually help prevent Alzheimer’s disease? A new report from the Institute on Scientific Information on Coffee in Europe…
Amyloid-beta protein buildup, inflammation, tau accumulation and shrinking brain size: These are all factors that define neurodegenerative diseases like Alzheimer’s. It turns out that…
When biotechnology company Biogen announced the cancellation of the trial for their Alzheimer’s drug aducanumab, nearly 3,500 trial participants were left in limbo. Now,…
SAN DIEGO — I’m not a doctor. I’m not a scientist. I barely made it through my math and science classes in college. Actually,…
SAN DIEGO — The scientific data was virtually unreadable, the explanations often too complex for the layman or woman to understand. But there was…
A highly anticipated Alzheimer’s conference opened here last night with reports about a powerful new drug for treating dementia-related delusions and promising developments in…
The tangled amyloid and tau proteins that accumulate in the aging brains of people with Alzheimer’s have been a major focus for drug developers…
Reporting on a procedure performed last year, scientists at the West Virginia University Rockefeller Neuroscience Institute said today that using low-intensity focused ultrasound is…
SAN DIEGO — Headlining a top Alzheimer’s conference this week, the pharmaceutical company Biogen will for the first time share the data that led…
As the quest to understand the complexities of Alzheimer’s continues, researchers have now identified genetic mutations related to autism that may play a role…
Scientists have largely focused on the buildup of beta-amyloid as one of the major drivers of Alzheimer’s disease, but more and more research is…